The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).
https://ift.tt/2JzJJBH
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου